BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 10375091)

  • 1. Primary CNS lymphoma.
    Maher EA; Fine HA
    Semin Oncol; 1999 Jun; 26(3):346-56. PubMed ID: 10375091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary central nervous system (CNS) lymphoma in immunocompetent patients.
    Plasswilm L; Herrlinger U; Korfel A; Weller M; Küker W; Kanz L; Thiel E; Bamberg M
    Ann Hematol; 2002 Aug; 81(8):415-23. PubMed ID: 12223997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary central nervous system lymphoma.
    Gerstner ER; Batchelor TT
    Arch Neurol; 2010 Mar; 67(3):291-7. PubMed ID: 20212226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment options for central nervous system lymphomas in immunocompetent patients.
    Jahnke K; Thiel E
    Expert Rev Neurother; 2009 Oct; 9(10):1497-509. PubMed ID: 19831839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma.
    Bierman P; Giglio P
    Hematol Oncol Clin North Am; 2005 Aug; 19(4):597-609, v. PubMed ID: 16083825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of combined-modality therapy for primary and secondary malignant lymphoma of the central nervous system (CNS).
    Kawamura T; Koga S; Okamoto M; Kanno T; Iwamura H
    Radiat Med; 2001; 19(3):145-9. PubMed ID: 11467381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary CNS lymphoma.
    Gerstner E; Batchelor T
    Expert Rev Anticancer Ther; 2007 May; 7(5):689-700. PubMed ID: 17492932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current management of primary central nervous system lymphoma.
    Schultz CJ; Bovi J
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):666-78. PubMed ID: 20159361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary non-Hodgkin's malignant lymphoma of the central nervous system].
    Monjour A; Poisson M; Kujas M; Delattre JY
    Rev Neurol (Paris); 1992; 148(10):589-600. PubMed ID: 1295053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary CNS lymphoma in immunocompetent patients.
    Sierra del Rio M; Rousseau A; Soussain C; Ricard D; Hoang-Xuan K
    Oncologist; 2009 May; 14(5):526-39. PubMed ID: 19433528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary CNS lymphoma.
    Batchelor T; Loeffler JS
    J Clin Oncol; 2006 Mar; 24(8):1281-8. PubMed ID: 16525183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary central nervous system lymphomas].
    Hrudková M; Belada D; Smolej L; Zák P; Malý J
    Vnitr Lek; 2010 Aug; 56(8):795-800. PubMed ID: 20845611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary central nervous lymphoma presenting as bilateral cerebellopontine angle lesions: a rare case report.
    Jaiswal AK; Mahapatra AK; Sharma MC
    J Clin Neurosci; 2004 Apr; 11(3):328-31. PubMed ID: 14975433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical presentation of primary central nervous system non-Hodgkin lymphoma in immunocompetent young adults.
    Cheatle JT; Aizenberg MR; Weinberg JS; Surdell DL
    World Neurosurg; 2013; 79(3-4):593.e9-13. PubMed ID: 22885166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary central nervous system lymphoma: overview of current treatment strategies.
    Brastianos PK; Batchelor TT
    Hematol Oncol Clin North Am; 2012 Aug; 26(4):897-916. PubMed ID: 22794289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on primary central nervous system lymphoma.
    Iwamoto FM; DeAngelis LM
    Hematol Oncol Clin North Am; 2006 Dec; 20(6):1267-85. PubMed ID: 17113462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances for the treatment of primary central nervous system lymphoma (review).
    Yamanaka R; Tanaka R
    Oncol Rep; 2004 Sep; 12(3):563-8. PubMed ID: 15289838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of primary central nervous system lymphoma in the immunocompetent patient].
    Sierra Del Rio M; Benouaich-Amiel A; Psimaras D; Dehais C; Hoang-Xuan K
    Rev Neurol (Paris); 2008; 164(6-7):569-74. PubMed ID: 18565356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma.
    Cheng T; Forsyth P; Chaudhry A; Morris D; Glück S; Russell JA; Stewart DA
    Bone Marrow Transplant; 2003 Apr; 31(8):679-85. PubMed ID: 12692608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
    Bessell EM; Graus F; Lopez-Guillermo A; Lewis SA; Villa S; Verger E; Petit J
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):501-8. PubMed ID: 15145169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.